Pharmaceutical

KM Biologics’ mpox vaccine approved for emergency use by WHO

The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 million-dose donation by the Japanese Government.

Nov 21, 2024 - 06:00
KM Biologics’ mpox vaccine approved for emergency use by WHO
The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 million-dose donation by the Japanese Government.
Read the original article

Tags:

Previous Article

UK life science startups have trouble “scaling up” says Lord Vallance

Next Article

Tris Pharma receives ex-US approvals for ADHD treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

FDA moves to stop vape shops from selling Elf Bar, Esco...

Jun 22, 2023

Tired of ‘dead end’ approach, herpes patients mobilize to demand government action

Tired of ‘dead end’ approach, herpes patients mobilize ...

Apr 21, 2023

Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition

Lilly bolsters IBD portfolio with $3.2bn Morphic acquis...

Jul 10, 2024